Back to Search
Start Over
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection.
- Source :
-
OncoImmunology . Jul2012, Vol. 1 Issue 4, p544-546. 3p. - Publication Year :
- 2012
-
Abstract
- We report that cryoablation of primary tumors synergizes with anti-CTLA-4 treatment to mediate rejection of secondary tumors in the TRAMP mouse model of prostate cancer. T cells, in particular CD8+ T cells specific for the TRAMP antigen SPAS-1, were enriched in both secondary tumors and spleens of combination-treated mice. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 21624011
- Volume :
- 1
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- OncoImmunology
- Publication Type :
- Academic Journal
- Accession number :
- 76531538
- Full Text :
- https://doi.org/10.4161/onci.19442